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Thymomas are rare tumors arising from thymic epithelial cells with incidence rates of approximately 2.5 per mil-
lion per year. Thymomas are rare before 25 years of age but 
show a wide age distribution (<10 to >80 years [mean 50–60 
years]) with no major sex predilection. Although thymomas 
are in general indolent neoplasms, all thymomas, irrespective 
of subtype, are considered malignant. Thymic carcinomas are 
set apart from thymomas as a diverse group of tumors with 
overt, often high grade, malignant behavior and are not fur-
ther discussed in detail here. Most thymomas are surgically 
removed, either as a primary intervention or after work-up, 
which may include a biopsy. This article provides an over-
view of issues related to handling, diagnosing, and reporting 
of both biopsies and surgical specimens of thymomas. Major 
considerations of the assessment of thymic tumors are accu-
rate subtyping and pathological staging, which hinges upon 
precise pathological management of specimens. Specific, 
detailed aspects of thymoma diagnosis and specimen handling 
are described in recent reviews.1,2 The majority of thymomas 
may be confidently diagnosed by following fairly straight-
forward algorithms as outlined below. However, it is recog-
nized that there are cases which defy certain classification; the 
issues surrounding these cases and how to deal with these, are 
described in a recent publication.3
THYMOMA SUBTYPING
Over the years numerous thymoma classifications have 
been introduced, used and have been replaced by newer or 
alternative schemes.4 Many classifications have attempted 
to use the histology and assumed histogenesis of the normal 
thymus as a basis, while other classifications have followed a 
more simplified approach, for instance by grouping thymomas 
in limited categories based on biological behavior.5 Although 
no classification is perfect, the WHO classification is currently 
the advocated classification. In this classification, appreciation 
of “organotypical” features (i.e., histological characteristics 
mimicking those observed in the normal thymus) including 
growth pattern (encapsulation and a “lobular architecture”) 
and cellular composition (summarized in Table 2) is generally 
retained.
In the WHO classification, the five main histological 
thymoma subtypes are labeled by letters or letters and num-
bers and distinguished from very rare other thymoma entities 
(Table 1).The five main subtypes (A, AB, B1, B2, and B3) can 
be broadly divided into thymomas containing spindled neo-
plastic epithelial cells (A, AB) and thymomas composed of 
epithelioid neoplastic epithelial cells (B1–3) (Fig. 1). The fur-
ther subdivision depends on the content of neoplastic epithe-
lial cells and nonneoplastic immature T-cells; in type A and B3 
thymoma there is a paucity or even lack of immature T-cells 
throughout the respective tumors that show densely packed 
spindle cells (type A; Fig. 1A, B) or sheets of polygonal (type 
B3) tumor cells (Fig. 1R, S), whereas there is a variable and 
reciprocal abundance of immature T-cells and tumor cells in 
type AB, B1, and B2 thymomas (Fig. 1E–Q).3,6 Despite the fact 
that the epithelial cell density (B-type thymomas) and mor-
phology (A- and AB-type thymoma versus B-type thymoma) 
determines the broad subtype, initial assessment of a thymic 
tumor on low power begins with recognition of its associated 
lymphoid component (Fig. 2). In contrast to type A and B3 
thymoma, type AB, B1, and B2 thymomas show an abundance 
of immature lymphocytes (“thymocytes”) either focally (most 
type AB thymoma) or diffusely (rare type AB, all type B1 and 
B2 thymomas). Confirmation of the immature phenotype of 
the lymphocytic component is easily achieved by immunohis-
tochemistry, which is typified by positivity for CD1a, TdT, and 
CD99. The density of the lymphocytic component is a help-
ful feature in the different subtypes of B-thymoma. In type 
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TABLE 1.  Rare Types of Thymoma6
Micronodular thymoma
Metaplastic thymoma
Microscopic thymoma
Sclerosing thymoma
Lipofibroadenoma
ITMIG DEFINITIONS AND POLICIES
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B1 thymoma, the lymphocytic population obscures the epi-
thelial cells (Fig. 1K). The epithelial cells may be highlighted 
by a cytokeratin (CK) immunostain, which reveals a charac-
teristic anastomosing network of epithelial cells which then 
appears far denser than is often initially appreciated (Fig. 1L). 
Clusters of three or more epithelial cells should not be pres-
ent in B1 thymoma.3 A typical feature, essentially required to 
establish a diagnosis of B1 thymoma, is “medullary islands” 
(MIs). MIs mimic medullary regions of the normal thymus. 
In H&E stained sections, they appear as pale staining regions 
that are either completely or partially surrounded by deep-
blue staining cortical areas. MIs consistently harbor at least 
a few keratin-positive epithelial cells, mainly mature, rather 
than TdT(+) immature T-cells and CD20(+) B cells, while 
FIGURE 1.  Main thymoma sub-
types. A–D, Type A thymoma: (A) low 
power, (B) medium power H&E stain, 
(C) cytokeratin stain, (D) p63 stain. 
E–I, Type AB thymoma: (E) low power 
overview, (F) “A” area composed of 
spindle cells devoid of lymphocytes, 
(G) “B” area with moderately dense 
lymphocyte population; (H, I) cyto-
keratin (H) and TdT (I) stain of adja-
cent “A” and “B” areas. J–M, Type B1 
thymoma: low (J) and high (K) power 
H&E stain; cytokeratin (L) and TdT 
(M) stain, with sparing of a medullary 
island. Note residual normal thymic 
tissue in (J). N–Q, Type B2 thymoma: 
low (N) and high (O) power H&E 
stain; cytokeratin (P) and TdT (Q) 
stain. R–U, Type B3 thymoma: low 
(R) and high (S) power H&E stain; 
cytokeratin (T) and TdT (U) stain.
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Hassall’s corpuscles and desmin-positive myoid cells are fac-
ultative constituents (Fig. 1M).
Combined with a less dense lymphocytic infiltrate, the 
presence of an easily identifiable epithelioid epithelial com-
ponent establishes type B2 thymoma (Fig. 1N–Q). In B3 thy-
moma, only a sparse or no lymphoid population is present, 
overshadowed by confluent sheets of epithelioid cells. The 
confluence of epithelial cells in B3 thymoma results in a squa-
moid appearance (Fig. 1R–U). However, defining features of 
true squamous differentiation (keratinization and/or intercel-
lular bridges) are generally not present.
Regardless of the B-type thymoma, the cytology of the 
epithelial cells is fairly constant, although variation from case 
to case is noted and in general the aspect of the epithelial cells 
differs subtly between B-thymoma subtypes. It should be noted 
that in some classifications (including the current 2004 WHO 
classification) the cytology of the epithelial cells is a deter-
mining factor in the classification of the thymoma.3,6 In B-type 
thymoma, the epithelial cells typically have ill-defined pale to 
eosinophilic cytoplasm and centrally placed variably vesicular 
nuclei with an identifiable nucleolus. Rarely otherwise typical 
type B3 thymoma may focally show mildly atypical spindle 
cells. By contrast, the existence of a type B3 thymoma show-
ing spindle cells throughout the tumor and its distinction from 
the recently described “atypical variant of type A thymoma”7 
is currently not clear.3
Type A and type AB thymoma harbor epithelial cells 
that are spindle shaped (i.e., longer than wide, with tapering 
nuclei and cell boundaries) (Fig. 1A–I). The spindle cells may 
be arranged in a surprising variety of architectural patters, 
including long or short fascicles, swirls, whorls, rosettes, and 
solid sheets. Hyperchromasia and atypia is unusual in type 
A thymoma, the proliferative activity is low. Recently, a vari-
ant of type A thymoma, designated “atypical variant of type 
A thymoma,” has been proposed, in which comedonecrosis, 
atypia and increased mitotic activity are present.7,8 To date 
there is insufficient data to determine the clinical significance 
of this variant.3
In most type AB thymoma both a lymphocyte-poor 
(type A-like) and a lymphocyte-rich (type B-like) compo-
nent are combined (Fig. 1E–I), while a minority of cases may 
appear lymphocyte-rich throughout the tumor. Areas with typ-
ical spindled epithelial cells may be intimately admixed with 
lymphocyte-rich areas or may be sharply demarcated from 
them. Of note the lymphocyte-rich areas may show a spec-
trum of epithelial cell morphologies ranging from (obligatory) 
spindle cells to polygonal epithelial cells resembling those in 
type B1 or B2 thymomas. Small areas of medullary differen-
tiation (MIs) as encountered in type B1 thymomas may also 
occur in the lymphocyte-rich regions of AB thymomas.
Additional rare thymoma types exist which include 
micronodular thymoma with lymphoid stroma and metaplas-
tic thymoma (Table 1). Micronodular thymoma is composed 
of spindled cells arranged in compact nodules with an asso-
ciated extra-epithelial lymphoid population. In contrast to 
typical type A thymoma, the lymphoid component is mostly 
composed of mature (CD20/CD79a-positive) B-cells, often 
forming lymphoid follicles. A component of micronodular 
thymoma is sometimes (up to 10% of cases) present in type 
A thymoma and conversely micronodular thymoma often 
contains areas of type A thymoma.9,10 For more detailed 
information on the rare thymoma types, the reader is referred 
to the WHO.6
It is increasingly recognized that thymomas are not as 
“pure” as previously assumed, with the exception of type A 
and (inherently) AB thymoma. The B-type thymomas may 
show a degree of heterogeneity.11 To allow for the heteroge-
neity the presence of different subtypes should be reported 
in 10% increments.3 Because AB thymoma is already a 
mixed type thymoma this rule does not apply. Owing to the 
FIGURE 2.  Flowchart for initial 
hematoxylin and eosin-based subtyp-
ing of thymoma; final subtyping 
must take all criteria into account as 
described in the text.
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heterogeneity which may be present in thymomas and the dif-
ferences in interpretation of histological findings a degree of 
interobserver variability is inevitable as has been shown in 
previous studies.12,13
Furthermore, because of the potential heterogeneity of 
thymomas, caution should be used in subtyping thymomas 
on biopsies; ideally subtyping of thymomas is performed on 
the resection specimen. The diagnostic criteria for thymoma 
subtypes are given in Tables 2 (organotypical features) and 3 
(diagnostic features).
IMMUNOHISTOCHEMISTRY
For many resected thymomas the histology is distinct 
and diagnostic. However, accurate subtyping can be enhanced 
by the judicious use of specific antibodies, many of which are 
commonplace in the pathology laboratory. Furthermore, in 
biopsies, immunohistochemistry can be helpful to distinguish 
thymomas from its mimickers. Highly specific antibodies 
(such as AIRE, FoxN1, and CD205) are of limited general use 
in diagnostic thymic histopathology and are usually reserved 
for research applications. In selected cases, refuge may be 
sought to these stains in a referral center. The stains which are 
regularly used in thymic pathology are listed in Table 4. For 
non-thymic tumors which may enter the differential diagnosis, 
the reader is referred to alternative reviews.14
CK stains are useful to determine the density and pat-
tern of the thymic epithelial network when deciding on the 
B subtype (and possible relative proportions of subtypes). A 
delicate network of CK-positive epithelial cells is seen in B1 
thymoma (Fig. 1L). A network of CK-positive epithelial cells 
denser than in the normal thymic cortex and/or clusters of epi-
thelial cells are present in B2 thymoma (Fig. 1P). Sheets of 
CK-positive tumor cells define B3 thymomas (Fig. 1T). p63 
is a useful alternative to CK staining when assessing the epi-
thelial density in a thymoma as it has a similar staining profile 
and sometimes might be easier to interpret. As the CK pro-
file of the epithelial cells in B-type thymomas overlaps con-
siderably, CK subtyping is of little use in routine diagnosis 
and a pan-CK stain suffices. The immature phenotype of the 
lymphoid population may be confirmed by CD3/TdT stains. 
Alternatively or complementary, CD1a and CD99 may be 
used. In contrast to the lymphoid component of thymomas, 
the MIs in B1 thymoma contain mature (CD3+/TdT−) T-cells 
and mature B-cells.
The spindled epithelial cells of type A and AB thy-
moma are likewise pan-CK and p63 positive and in addition 
may express CD20. As mentioned previously, the presence of 
an obvious TdT+/CD1a+/CD99+ positive lymphoid popula-
tion in a spindle cell thymoma points to a type AB thymoma. 
Mediastinal tumors composed of spindle cells should arouse 
suspicion of neuroendocrine tumors; therefore, a low threshold 
is advocated for the application of neuroendocrine markers.
DIFFERENTIAL DIAGNOSIS
Differential diagnostic considerations are particularly 
relevant when (anterior) mediastinal masses are sampled by 
needle biopsy (Table 5). The differential diagnosis of lympho-
cyte-rich (AB/B1-2) thymomas includes thymic hyperplasia 
and non-Hodgkin lymphoma. Thymic hyperplasia may be 
very difficult to distinguish from B1 thymoma and AB type 
thymoma with a dense lymphocytic population. Septation, a 
more pronounced fibrous capsule and strong predominance of 
cortical over medullary areas are typical features of B1 thy-
moma. However, it may be impossible to distinguish thymic 
hyperplasia and B1 thymoma on a biopsy, where sampling is a 
major consideration. Type B2 thymoma has a denser epithelial 
component, which is more easily appreciated on CK and p63 
staining. In addition MIs are characteristic (required) for B1 
thymoma and sparse or absent in B2 thymoma. Conversely, 
perivascular spaces are generally easily seen in B2 thy-
moma but often barely detectable in B1 thymoma and thymic 
hyperplasia.
T-cell lymphoblastic lymphoma (T-LBL) often shares 
the immunohistochemical phenotype of the lymphocytes in 
B1 thymoma. Although the gross appearance of thymoma 
and T-LBL is different, biopsy specimens of thymoma in par-
ticular may be misinterpreted as T-LBL if the epithelial cells 
are not recognized. The lymphocytes in T-LBL are atypical 
with a very high mitotic index and necrosis may be present 
which is not seen in B1 thymoma. Immunohistochemistry to 
distinguish T-LBL and type B1 thymoma in small biopsies 
is of limited use, the blasts of T-LBL and immature lympho-
cytes of type B1 thymoma have a similar immunophenotype. 
However, a diffuse keratin-positive epithelial cell network 
TABLE 3.  Diagnostic Features of Thymoma Subtypes
A Sparse or no immature lymphocytes
AB Spindled epithelial 
cells
+/− Epithelioid/polygonal tumor 
cells, focal or diffuse abundance 
of immature lymphocytes3
B1 Thymus-like architecture with distinct cortical areas and 
medullary islands (required), dispersed epithelial cells, 
dense immature lymphocytic population, low power 
“blue” appearance
B2 Increased density of dispersed or clustered epithelial 
cells (≥3 adjacent cells), moderately dense immature 
lymphocytic population, low power “blue” appearance
B3 Sheets of epithelial cells, sparse or (rarely) absent immature 
lymphocytic population, low power “pink” appearance
TABLE 2.  Histological Findings Mimicking Features of the 
Normal Thymus (“Organotypical Features”)
Type
Thymicorganotypical  
Features A AB B1 B2 B3
Lobulation/septation/ 
encapsulation
+ + + + +/−
Medullary differentiation  
(islandsa)
− −/+ Required −/+ −
Hassall’s corpuscles − −/+ +/− −/+ −/+
Perivascular spaces − −/+ +/− + ++
aMedullary islands are pale staining small areas in the dense purple background of 
B1 and although considerably less frequent B2 thymoma. These areas are almost devoid 
of immature thymocytes but contain a compliment of mature B- and T-cells.
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supports thymoma and argues against T-LBL. A potential 
diagnostic pitfall is entrapped epithelial or mesothelial cells 
in biopsies of T-LBL which are highlighted by a CK stain. In 
equivocal cases molecular analysis (T-cell receptor gene rear-
rangement) may be undertaken.
Type B3 thymoma is distinguished from B2 thymoma by 
the sparse often almost absent lymphocytic component (Fig. 
1N, O; R, S). The confluent epithelial cell population of B3 thy-
moma with its sparse lymphocytic population imparts a “pink” 
low power appearance (Fig. 1R), contrasting with the low-power 
“blue” appearance of B1 and B2 thymoma (Fig. 1J, N), owing to 
the dense lymphoid component.
Distinguishing B3 thymoma from non-keratinizing thy-
mic carcinoma may be difficult. B3 thymoma generally retains 
a lobular growth pattern, may have perivascular spaces, mild 
to moderate atypia and TdT positive lymphocytes, findings 
that are not seen in thymic carcinoma. Conversely, obvious 
desmoplasia strongly suggests thymic carcinoma.
Thymic carcinoma may exhibit a “typical” immunohis-
tochemical staining pattern (CD5+/CD117+/diffuse Glut1+/
Muc1+) which often contrasts with that of thymoma. Despite 
the morphological and immunohistochemical differences, 
ambiguous cases occur and guidelines of how to deal with 
these cases have been proposed.3 As a general rule in equivo-
cal cases, morphological features overrule immunohisto-
chemical findings.
In type A thymoma, neuroendocrine tumors and para-
ganglioma should be considered in the differential diagno-
sis. Awareness of these possibilities and the application of 
appropriate immunohistochemical markers will help in the 
diagnosis of these tumors. Mesenchymal tumors, in particular 
solitary fibrous tumor and synovial sarcoma, may enter the dif-
ferential diagnosis. Solitary fibrous tumor however is negative 
for CK and positive for CD34. Synovial sarcoma is a densely 
cellular spindle cell tumor, CK is usually only focally positive 
and in doubtful cases additional stains and molecular analy-
sis may be performed. Rarely, B3 thymoma may consist of 
atypical spindle cells. As previously mentioned, a provisional 
entity, “atypical A” thymoma has been proposed of which the 
features will overlap with those of spindle cell B3 thymoma.3
HANDLING OF SURGICAL SPECIMENS
A good working relation and a low threshold for com-
munication should exist between thoracic surgeons and 
pathologists dealing with thymic resection specimens. The 
published guidelines for handling thymic resection specimens 
are comprehensive and should be followed as close as pos-
sible.1 Orientation of the specimens may be accomplished 
by various methods (sutures, clips); optimal orientation is 
achieved by pinning the specimen to a board. Notes and fur-
ther information should be provided. For research purposes 
fresh tissue samples may be procured, taking care that sam-
ples are selected from nonmargin critical areas and preferably 
after inking the specimen. After fixation regular sampling of 
the specimen is performed, with at least one block per cm of 
tumor and generous sampling of close margins.1 Thymomas 
are almost always and at least partially encapsulated; the cap-
sule is often only loosely adherent and easily tears or retracts 
upon manipulation of the specimen. Care should be taken to 
preserve the capsule as this constitutes the plane of dissection 
and surface of the specimen. Resected thymomas should be 
accurately staged, an update of staging considerations is pub-
lished elsewhere in this volume.
Patients with thymomas may be treated by neoadjuvant 
chemotherapy before surgical removal. Classification should 
still be attempted after neoadjuvant therapy. A spectrum of 
regressive changes may be encountered. The lymphocytic 
component may be depleted in lymphocyte-rich thymoma 
subtypes, blurring the distinction between B-type thymomas 
and type A versus AB thymoma. Conversely, lymphocyte-
poor thymomas (A and B3) appeared more viably following 
neoadjuvant treatment.15
FROZEN SECTIONS
There are few indications for performing frozen sec-
tions on tumors from the anterior mediastinum.1 Incidentally 
discovered masses in the anterior mediastinum, for instance 
when performing cardiac bypass surgery, may be submitted 
for frozen section. Considering the differential diagnosis, care 
must be taken not to overinterpret the lymphocytic component 
TABLE 4.  Immunohistochemical Studies in Thymoma
panCKa p63 EMA CD20 TdT (ly)
A + + −/+ +/− +/− CD20+ epithelial cells
AB + + −/+ +/− + CD20+ epithelial cells
B1 + + +b + CK staining reveals a fine 
continuous network.
B2 + + + Clusters of CK- 
positive cells (≥3 
adjacent cells)
B3 + + −/+ +/− Sheets of epithelial 
cells; sparce or no 
TdT+ lymphocytes
aVery rare thymomas loose reactivity with anti-panCK antibodies. In such cases, p63 
is usually positive in epithelial cell nuclei.ly, lymphocytes.
bMedullary islands:
T-cells: CD3+/Tdt−/CD1a−.
B-cells: CD20+/79a+
TABLE 5.  Differential Diagnosis of the Five Main Types of 
Thymoma
Biopsy Resection
Type A thymoma Neuroendocrine tumors
Paraganglioma
Spindle cell thymic 
carcinoma
Mesenchymal tumors
Type AB thymoma
Micronodular thymoma
Type AB thymoma
“Atypical type A thymoma”
Type AB thymoma Type A thymoma
Type B1 thymoma
Type A thymoma
Type B1 thymoma Thymic hyperplasia
T-lymphoblastic 
lymphoma
Type B2 thymoma
Type B2 thymoma
Type B2–3  
thymoma
Thymic carcinoma
T-lymphoblastic 
lymphoma
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of B-type thymomas as T-LBL. Discriminating B3 thymoma 
from thymic carcinoma on frozen section is fraught with dif-
ficulty and should not be undertaken. Confirmation of the 
presence of a thymic epithelial tumor suffices with deferral to 
permanent sections for a definite diagnosis. Similarly, frozen 
sections showing a spindle cell neoplasm may lead to an erro-
neous diagnosis of sarcoma. Because thymomas are typically 
circumscribed and often encapsulated tumors, assessment of 
margins by frozen section is rarely necessary and should only 
be requested if there are immediate therapeutic consequences.
REPORTING
Clear-cut reporting of thymic resection specimens 
is paramount to optimal patient management. Items which 
should be included in the final report are the following: (1) 
type of resection; (2) encapsulation and integrity of the cap-
sule; (3) thymoma subtype, including the various histological 
patterns, estimated in 10% increments for tumor heterogene-
ity3; (4) Masaoka-Koga stage; (5) margin status, including 
documentation of all margins with less than 3 mm clearance; 
(6) effects of neoadjuvant treatment (if applicable).1,15
PREOPERATIVE DIAGNOSIS
If a biopsy procedure is performed for an anterior medi-
astinal mass usually only sparse tissue will be available for 
ancillary studies. Therefore, care must be taken to ensure 
optimal selection of markers. Clinical details, in particular 
age and symptoms (particularly myasthenia gravis status), can 
provide important information on the differential diagnosis 
and subsequent selection of markers (Tables 4 and 5). A con-
siderable proportion of patients (up to 1/3) with a thymoma 
are asymptomatic and a mediastinal mass is discovered inci-
dentally. Before definite treatment, a biopsy procedure may 
be part of the work-up. Guidelines for the work-up of biop-
sies from mediastinal masses in general have been published, 
including suggestions for markers.2,14 Obviously, in a biopsy 
only limited aspects of the typical thymoma architecture are 
present. For instance, septation, lobulation, and perivascular 
spaces are poorly preserved in needle biopsies, limiting diag-
nostic certainty.
If a needle core biopsy from an anterior mediastinal 
mass yields a dense lymphoid population with an epithelial 
component, or a CK-positive spindle cell population, thy-
moma can be suggested. However, given the heterogeneity of 
thymomas and the mixed components of type AB thymoma, 
providing a conclusive diagnosis of a specific thymoma sub-
type is not advocated. A generic diagnosis of “thymoma” suf-
fices to which may be added a comment on possible subtype.
Although accurate subclassification of thymoma is not 
possible on cytological specimens obtained by FNA of medi-
astinal masses, the generic diagnosis of thymoma may be 
suggested.16–18 Lymphocyte-rich smears with scattered epithe-
lial cells suggest a B-type thymoma. Failing to recognize the 
epithelial cells may result in a misdiagnosis of reactive lymph 
node or T-LBL. In addition to the possibility of a diagnosis 
of type A or type AB thymoma, aspirates derived from medi-
astinal masses containing spindled cells raise the differential 
diagnostic possibilities of neuroendocrine tumors and mesen-
chymal tumors.
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